Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cutaneous Melanoma Detection and Management, and Melanoma and MAPK Pathways.
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma
Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: a multicentre retrospective study
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study
Ipilimumab (IPI) alone or in combination with anti-PD-1 (IPI+PD1) in patients (pts) with metastatic melanoma (MM) resistant to PD1 monotherapy.